Cover Image

Effective administration of the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining effective administration of the 340B Drug Pricing Program, June 19, 2018.

Bibliographic Details
Corporate Author:	United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Publishing Office, 2020.
Series:	S. hrg. ; 115-827
Subjects:	United States. > Health Resources and Services Administration > Rules and practice. 340B Drug Pricing Program (U.S.) > Auditing. Prescription pricing > Government policy > United States. Poor > Pharmaceutical assistance > United States. Economically Disadvantaged. United States. > Health Resources and Services Administration Auditing Poor > Pharmaceutical assistance Prescription pricing > Government policy United States. Legislative hearings. Rules.
Online Access:	https://purl.fdlp.gov/GPO/gpo141549

Similar Items

Examining how covered entities utilize the 340B drug pricing program : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, October 11, 2017.
Published: (2019)

Examining the 340B drug pricing program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, March 24, 2015.
Published: (2015)

Opportunities to improve the 340B drug pricing program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, July 11, 2018.
Published: (2019)

Perspectives on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining perspectives on the 340B drug discount program, March 15, 2018.
Published: (2020)

Examining HRSA's oversight of the 340B Drug Pricing Program : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, July 18, 2017.
Published: (2018)

The patient perspective : the devastating impacts of skyrocketing drug prices on American families : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, July 26, 2019.
Published: (2019)

Oversight and administration of the 340B drug discount program : improving efficiency and transparency : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, December 15, 2005.
Published: (2006)

Oversight and administration of the 340B drug discount program : improving efficiency and transparency : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, December 15, 2005.
Published: (2006)

Prescription drug price inflation : are prices rising too fast? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, December 8, 2009.
Published: (2012)

Prescription Drug Sunshine, Transparency, Accountability and Reporting Act : report (to accompany H.R. 2113) (including cost estimate of the Congressional Budget Office).
Published: (2020)

The role of patents and regulatory exclusivities in drug pricing /
by: Hickey, Kevin J., et al.
Published: (2021)

Unsustainable drug prices : hearing before the Committee on Oversight and Reform, House of Representatives.
Published: (2020)

Drug pricing and intellectual property : the legislative landscape for the 117th Congress /
by: Hickey, Kevin J., et al.
Published: (2021)

The cost of prescription drugs : examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining the cost of prescription drugs, focusing on examining the President's blueprint 'American Patients First' to lower drug prices, June 12, 2018.
Published: (2020)

Lower Drug Costs Now Act of 2019 : report of the Committee on Energy and Commerce.
Published: (2019)

The price of health : the modern pharmaceutical enterprise and the betrayal of a history of care /
by: Kinch, Michael, 1966-, et al.
Published: (2021)

Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony before the Subcommittee on Health, Committee, Energy and Commerce, House of Representatives /
by: Draper, Debra
Published: (2018)

Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019.
Published: (2021)

Sudden price spikes in decades-old prescription drugs : inside the monopoly business model : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, March 17, 2016.
Published: (2022)

Ten years later : a look at the Medicare prescription drug program : hearing before the Special Committee on Aging, United States Senate, One Hundred Thirteenth Congress, first session : Washington, DC, Wednesday, May 22, 2013.
Published: (2016)

The politics of the international pricing of prescription drugs /
by: Harrison, Christopher Scott
Published: (2004)

Frequently asked questions about prescription drug pricing and policy /
by: Kirchhoff, Suzanne M., et al.
Published: (2018)

Valeant Pharmaceuticals' business model : the repercussions for patients and the health care system : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, April 27, 2016.
Published: (2022)

Blink Health : reinventing pharma industry value chain in the United States /
by: Agnihotri, Arpita, et al.
Published: (2022)

Pricing a new drug /
by: Munshaw, Supriya, et al.
Published: (2019)

PBS newshour.
Published: (2023)

Examining oversight reports on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining oversight reports on the 340B Drug Pricing Program, May 15, 2018.
Published: (2020)

Effects of medicare's drug pricing on other purchasers.
Published: (2007)

Manufactured crisis : how devastating drug price increases are harming America's seniors.
Published: (2018)

Public attitudes toward prescription costs and the drug industry : a report /
Published: (1955)

Weatherization Enhancement and Local Energy Efficiecny Investment and Accountability Act of 2019 : report (to accompany S. 983) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Skyrocketing prescription drug costs : effects on senior citizens : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session, Lewiston, ME, April 15, 1992.
Published: (1993)

Out-of-pocket cost and acquisition of prescribed medicines, United States, 1973 /
by: Choi, Jai W.
Published: (1977)

The Prescription Drug Pricing Reduction Act of 2019 : report (to accompany 2543).
Published: (2019)

Expanding and improving Medicare : prescription drugs, an Oregon perspective : field hearing before the Special Committee on Aging, United States Senate, One Hundred Seventh Congress, second session, Beaverton, OR, August 15, 2002.
Published: (2002)

Expanding and improving Medicare : prescription drugs, an Oregon perspective : field hearing before the Special Committee on Aging, United States Senate, One Hundred Seventh Congress, second session, Beaverton, OR, August 15, 2002.
Published: (2002)

340B Drug Discount Program : information about hospitals that received an eligibility exception as a result of COVID-19.
Published: (2023)

Replacing average wholesale price : Medicaid drug payment policy.
Published: (2011)

Fundamentals of auditing.
by: Mautz, R. K. (Robert Kuhn), 1915-2002
Published: (1954)

Review of the relationship between Medicare Part D payments to local, community pharmacies and the pharmacies' drug acquisition costs /
Published: (2008)